Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes and stem-cell therapies slightly outperform PRP in improving hair and skin, but more research is needed.

Exosomes and stem-cell therapies slightly outperform PRP in improving hair and skin, but more research is needed.

The conclusion suggests that early signs of hidradenitis suppurativa may start in the hair follicle, with genetic and immune factors playing a role, highlighting the need for more research on the hair follicle's immune system.

Hair is culturally and economically valuable, and its weight is now used to measure the effectiveness of hair growth treatments.

Control inflammation and prevent further hair loss in folliculitis decalvans using medications and therapies.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Microneedles show promise for improving hair regrowth in alopecia.

Understanding hair growth pathways can lead to better hair loss treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

New treatments for hair loss show promise with advanced therapies and better targeting.

Psoriatic alopecia is a challenging hair loss condition linked to psoriasis, needing better diagnosis and personalized treatments.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

The guideline recommends using specific drugs and surgery together for treating hidradenitis suppurativa effectively.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

HS needs personalized treatment plans and more research.

The congress highlighted concerns about the effectiveness of over-the-counter nail treatments, the link between hair loss and daily care products, and the safety of skin treatments during COVID-19.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Hidradenitis suppurativa may be a type of autoinflammatory skin disease linked to gene mutations and immune system issues.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Biologicals are increasingly used in medicine and cosmetics, especially for skin and hair treatments, but more research is needed.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Cataract surgery in Europe varies in frequency and cost between countries.

New treatments for alopecia areata show promise, but no cure exists and responses to treatments vary.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Biologics and JAK inhibitors may improve treatment for scarring alopecias.